SEC Comment Letter 0000000000-23-000106 to Rennova Health, Inc. (RNVA) (CIK 0000931059)
Rennova Health, Inc. (RNVA) (CIK 0000931059)
Date: Jan. 4, 2023 · CIK: 0000931059 · Accession: 0000000000-23-000106
AI Filing Summary & Sentiment
File numbers found in text: 333-269077
Letter
United States securities and exchange commission logo January 4, 2023 Seamus Lagan Chief Executive Officer Rennova Health, Inc. 400 South Australian Avenue, Suite 800 West Palm Beach, Florida 33401 Re:Rennova Health, Inc. Registration Statement on Form S-1 Filed December 30, 2022 File No. 333-269077 Dear Seamus Lagan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Thomas Cookson
Show Raw Text
United States securities and exchange commission logo
January 4, 2023
Seamus Lagan
Chief Executive Officer
Rennova Health, Inc.
400 South Australian Avenue, Suite 800
West Palm Beach, Florida 33401
Re:Rennova Health, Inc.
Registration Statement on Form S-1
Filed December 30, 2022
File No. 333-269077
Dear Seamus Lagan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Thomas Cookson